Pursuant to Regulation 30 Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) (as amended), Anuh Pharma has informed that ICRA ('ICRA’s Credit Ratings) has reaffirmed and revised the outlook from ‘Stable’ to ‘Positive’ of following Instruments: Long-term -interchangeable (CC/WCDL) and Long-term/ short terminterchangeable (Bank Guarantee).
The above information is a part of company’s filings submitted to BSE.